Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Cilnidipine 20 mg tablet
Therapeutic Category
Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹119/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Cildraw 20 Tablet contains Cilnidipine 20 mg, a next-generation calcium channel blocker (CCB) that blocks both L-type and N-type calcium channels, offering superior blood pressure control and added cardiovascular protection. By relaxing vascular smooth muscles and inhibiting sympathetic nerve activity, Cilnidipine lowers systemic vascular resistance, reduces afterload on the heart, and provides stable control of hypertension with minimal reflex tachycardia. The 20 mg strength is typically prescribed in patients with moderate to severe hypertension or those requiring a higher dose when the 10 mg tablet is insufficient. Cilnidipine also offers renal protective benefits by reducing intraglomerular pressure and proteinuria, making it particularly beneficial for hypertensive patients with diabetes or chronic kidney disease. Its once-daily dosing improves compliance and provides sustained 24-hour blood pressure control.
Common side effects include dizziness, headache, flushing, ankle swelling (peripheral edema), and mild fatigue. Some patients may experience palpitations or gastrointestinal upset. Rarely, hypotension or gingival hyperplasia (gum overgrowth) may occur. Most side effects are transient and can be managed with dose adjustment or supportive care.
Cildraw 20 Tablet is indicated for the treatment of essential hypertension in adults. It is especially recommended in patients requiring stronger blood pressure control, including those with diabetic nephropathy, metabolic syndrome, or kidney involvement.
Cildraw 20 Tablet should be taken only under medical supervision. It is contraindicated in patients with severe aortic stenosis, cardiogenic shock, or known allergy to Cilnidipine. Caution is advised in patients with liver dysfunction, heart failure, or severe hypotension. The medication should not be stopped suddenly without consulting a doctor to avoid a sudden rise in blood pressure. It is not recommended during pregnancy or breastfeeding unless clearly indicated by a physician. Alcohol should be avoided or minimized as it can enhance the blood pressure-lowering effect and cause dizziness. Regular blood pressure monitoring and follow-ups are recommended to ensure safety and effective therapy.
Store Cildraw 20 Tablet in a cool, dry place below 30°C, away from moisture and direct sunlight. Keep the medicine in its original strip or container and out of the reach of children. Do not use after the expiry date printed on the pack.
Composition : Cilnidipine 10 mg tablet
Composition : Aspirin 75mg + Rosuvastatin 10mg + Clopidogrel 75mg Tablet
Composition : Aspirin 75 mg + Rosuvastatin 20 mg + Clopidogrel 75 mg capsule
Composition : Aspirin 75mg + Rosuvastatin 20mg + Clopidogrel 150mg Tablet
Composition : Rosuvastatin Calcium IP eq. to Rosuvastatin (as pellets) 20 mg. + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg. Excipients q.s.
Composition : Rosuvastatin 5 mg tablet
Composition : Rosuvastatin 5mg + fenofibrate 160 mg tablet
Composition : Rosuvastatin 40 mg tablet
Composition : Rosuvastatin (20mg) tablet
Composition : Rosuvastatin 20 mg + fenofibrate 160 mg tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Cilnidipine 20 mg Tablet has strong demand in the hypertension and cardiology segment, making it a profitable product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from the consistent demand for Cilnidipine 20 mg Tablet in blood pressure management. Including this product helps strengthen their antihypertensive and cardiology portfolio.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities for Cilnidipine 20 mg Tablet with monopoly rights, promotional support, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from attractive business margins, timely product availability, professional marketing support, and access to a trusted antihypertensive pharmaceutical range when partnering with Cafoli Lifecare for this formulation.
Medical distributors, stockists, wholesalers, and pharma professionals interested in Cilnidipine 20 mg Tablet can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk orders, pricing details, and distribution support services.